YOLK SAC TUMOR
Clinical trials for YOLK SAC TUMOR explained in plain language.
Never miss a new study
Get alerted when new YOLK SAC TUMOR trials appear
Sign up with your email to follow new studies for YOLK SAC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells target deadly childhood cancers
Disease control Recruiting nowThis early-stage study is testing whether genetically modified immune cells can fight solid tumors in children and young adults. Researchers collect patients' own immune cells, modify them to better recognize and attack cancer cells, then infuse them back into the body. The study…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists supercharge Patient's own cells to hunt down tough cancers
Disease control Recruiting nowThis early-stage study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have a specific marker called GPC3. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer, and then inf…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Tracking 1,151 childhood cancer survivors to unlock better future treatments
Knowledge-focused Recruiting nowThis study follows over 1,100 children and young adults who survived germ cell tumors to understand the long-term effects of their cancer treatments. Researchers will collect health information and analyze tumor samples to identify genetic patterns that could predict which patien…
Matched conditions: YOLK SAC TUMOR
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC